The role of acute combined peroxisome proliferator-activated receptors alpha and gamma stimulation on insulin action in humans
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 30 Jun 2017
At a glance
- Drugs Eicosapentaenoic acid; Pioglitazone
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 30 Jun 2017 Status changed from active, no longer recruiting to completed.
- 07 Mar 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 07 Mar 2012 Additional lead trial centre and investigator (Meredith Hawkins) identified as reported by ClinicalTrials.gov.